Article by Malik Burnett, Medical Jane – May 14, 2014
“For years now Δ9-tetrahydrocannabinol (THC) has been the most popular and widely researched cannabinoid in cannabis science. However, nowadays it seems like cannabidiol (CBD) has stolen the spotlight given its ability to provide therapeutic relief to children suffering from various epileptic disorders, while lacking the psychotropic effects (i.e. high) of THC. It’s even gotten to the point that state legislature are passing laws “CBD-only” medical marijuana legislation.
Given all of this, it is easy to see how CBD and THC can be viewed as being in competition. But the reality is that both compounds, along with as many as 66 other cannabinoids, play important roles in providing the therapeutic benefits associated with cannabis therapy. They work in conjunction with approximately 420 additional compounds (terpenes, flavonoids, etc.) to give cannabis its versatility in treating a multitude of medical ailments.”